Company Information

  

Address: RUE EDOUARD BELIN 12  
City: MONT-SAINT-GUIBERT 
State:  
Zip Code: 1435 
Telephone: 32 10 394 100 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Our legal and commercial name is Celyad SA. Prior to May 5, 2015, our corporate name was Cardio3 Biosciences SA. We are a limited liability company incorporated in the form of a naamloze vennootschap/société anonyme under Belgian law. We are registered with the Register of Legal Entities (RPM Nivelles) under the enterprise number 891.118.115. We were incorporated in Belgium on July 24, 2007 for an unlimited duration. Our fiscal year ends December 31. Our principal executive and registered offices are located at rue Edouard Belin 2 1435 Mont-Saint-Guibert, Belgium and our telephone number is +32 10 394 100. Our agent for service of process in the United States is C T Corporation System, with an address at 111 8th Avenue, New York, NY 10011. We also maintain a website at www.celyad.com. The reference to our website is an inactive textual reference only and the information contained in, or that can be accessed through, our website is not a part of this Annual Report.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
There's no share overview data.

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-1.64Total Liab/Total Assets0.39
Net Inc/Total Assets-0.73Total Liab/Inv Cap0.43
Net Inc/Inv Cap-0.81Total Liab/Comm Equity0.88
Pretax Inc/Net Sales-15.93Interest Coverage Ratio-11.66
Net Inc/Net Sales-15.93Curr Debt/Equity0.01
Cash Flow/Net Sales-12.55LTD/Equity0.04
SG&A/NetSales8.77Total Debt/Equity0.05
Asset Utilization   Liquidity  
Net Receivables Turnover4.96Quick Ratio4.58
Inventory TurnoverNACurrent Ratio4.58
Inventory Day SalesNANet Rec/Curr Assets0.01
Net Sales/Work Cap0.12Inv/Curr AssetsNA
Net Sales/PP&E1.08  

Income Statement (Millions)

  12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Revenues(Net Sales) 4.25 8.99 0.00 0.18
Cost of Goods Sold 0.62 0.06 0.00 0.14
Selling & Admin Exps 37.30 6.76 7.50 0.73
Operating Income -63.49 -27.01 -32.23 -19.89
Interest Exp 5.35 0.22 0.26 0.05
Pretax Income -67.72 -24.91 -31.63 -19.91
Other Income 1.12 2.33 0.59 0.34
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -67.72 -24.90 -31.63 -19.91

Balance Sheet (Millions)

Assets 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Cash & Short Term Investments 40.72 87.11 116.79 36.67
Receivables - Total 0.28 1.43 0.71 2.23
Inventories - Total NA NA NA NA
Total Current Assets 43.70 90.04 118.86 39.85
Net Property, Plant & Equipment 3.95 3.76 1.23 0.72
Total Assets 93.21 146.41 173.29 53.21
Liabilities        
Accounts Payable 5.76 8.54 9.32 4.89
Debt in Current Liabilities 0.52 1.39 0.98 0.94
Total Current Liabilities 9.54 11.89 12.48 7.32
Long-Term Debt 2.25 8.30 11.39 13.04
Total Liabilities 36.13 50.55 52.20 20.92
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 41.23 34.35 35.38 29.79
Retained Earnings -216.65 -130.82 -108.97 -86.17
Treasury Stock NA NA NA NA
Total Stockholders' Equity 57.08 95.86 121.09 32.29
Total Liabilities and Stockholders' Equity 93.22 146.41 173.29 53.21

Cash Flow Summary (Millions)

Categories 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Cash Provided by Operating Activities -53.37 -26.04 -29.66 -21.07
Net Cash Provided by Investing Activities 21.15 -31.81 -11.61 -2.14
Net Cash Provided by Financing Activities 0.73 3.20 120.08 33.59

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20130.00-19.96--
12/20140.18-19.91--
12/20150.00-31.63--
12/20168.99-24.90--
12/20174.25-67.72--
Growth RatesInfinity----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/18104614.01




Report Date : 7/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.